Business Context and Reporting Period
This Form 8-K is filed by Neuralstem, Inc. (not Palisade Bio, Inc.) on March 30, 2012, reporting events occurring on March 28 and March 29, 2012. The filing primarily serves to disclose the company's financial results for the fiscal year ended December 31, 2011, and to announce clinical trial safety data.
Key Financial Metrics
The filing references a press release (Exhibit 99.01) containing the financial results for the year ended December 31, 2011. However, the text of this 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are incorporated by reference only.
Material Changes and Clinical Updates
- Financial Results: The company announced its full-year 2011 financial results on March 29, 2012.
- Clinical Trial Update: On March 28, 2012, the company announced that safety results from the first 12 patients in its Phase I clinical trial for amyotrophic lateral sclerosis (ALS) were published in the peer-reviewed journal STEM CELLS on March 13, 2012.
Guidance, Outlook, and Risks
The filing text does not contain specific forward-looking guidance, management commentary on future performance, or a detailed discussion of risks and contingencies beyond the standard incorporation of the press releases. The document explicitly states that the information furnished under Items 2.02 and 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into subsequent filings unless specifically stated.
Investor Verification Checklist
- Review Exhibit 99.01 (Press Release dated March 30, 2012) for specific 2011 financial figures (revenue, net loss, cash position).
- Review Exhibit 99.02 (Press Release dated March 28, 2012) for detailed safety data regarding the ALS Phase I trial.
- Verify the company name discrepancy: The filing is for Neuralstem, Inc., despite the metadata request referencing Palisade Bio, Inc.
- Confirm the publication date and details of the ALS trial results in the journal STEM CELLS.